• Blackbox will install Ceres EcoLoop systems on its 120-acre property in Fairfield, Michigan
• After extensive study, BlackBox has found that VPD-based climate control is the best way to ensure crop health, maximize yield
• Company is in the process of expanding its Michigan operation

Hero Technologies (OTC: HENC) and its wholly owned subsidiary, BlackBox Systems and Technologies, are utilizing Ceres’s EcoLoop(TM), a high-tech, low-cost solution for growing cannabis. Blackbox will install the EcoLoop systems on its 120-acre property in Fairfield, Michigan (https://ibn.fm/Sgyju). The company anticipates that combining EcoLoop with its proprietary, state-of-the-art aeroponic system will increase its high-yield, high-profit cannabis crops. The move was reported in a recent MMJDaily article, which noted that, in January 2020, “Ceres introduced its EcoLoop climate control greenhouse system, a ground-coupled heat pump system designed to heat, cool and dehumidify Ceres’s sealed greenhouses. In effect, EcoLoop combines conventional above-ground HVAC systems with below-ground heat exchange mats. According to Ceres, EcoLoop can reduce energy consumption by up to 60% by decreasing the amount of energy that above-ground systems pull from the electrical grid or other resources.” “What first attracted us to EcoLoop was the installation,” says Marc Kasabasic of BlackBox Systems, an aeroponic cannabis cultivation system that provides optimal conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased efficiencies. “In Fairfield, we don’t have access to natural gas, so we felt that geothermal was the way to go. Also, the fact that the SunSense controller is VPD-based led us to choose Ceres.” The article observed that VPD-based controllers “optimize a ratio of temperature and humidity rather than managing each factor individually. After years of experimenting with environmental optimization, BlackBox has found that VPD-based climate control is the best way to ensure crop health and help maximize yield.” According to the article, BlackBox is in the process of expanding its Michigan operations. The company plans to break ground on 10 acres in September, with the construction of a 27,000-square-foot facility scheduled for completion next year. The new acreage will support four new greenhouses, with 12 more greenhouses in the planning stages. “We expect to harvest once a week, which is exceptional for a facility of this size,” said Kasabasic. “When we have the twelve additional greenhouses, we plan to harvest one greenhouse per week, then clean the entire area before starting again.” BlackBox will use Ceres’ SunChambers in its greenhouses; the SunChambers are sealed to improve environmental control, minimize use of resources and reduce costs. While Ceres provides turnkey greenhouse solutions, the company can also customize its designs to accommodate growers that have their own cultivation systems, such as BlackBox. The sealed SunChambers with VPD control offer BlackBox the ability to recapture condensate from the dehumidification process and recycle it, cutting down on water consumption, resulting in an estimated condensate flow of only 16 gallons per hour in each greenhouse. HENC is working toward a vertically integrated business model. The company’s strategic business plan includes cannabis genetic engineering, space for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator. The company is planning expansion in cultivation and dispensary operations into both Colorado, through its wholly owned subsidiary Mile High Green LLC, and Massachusetts, through wholly owned subsidiary MassCannabis LLC. In addition, Hero Technologies owns and operates two hemp websites: HighlyRelaxing.com under Highly Relaxing LLC and VeteranHempCo.com. For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

• Registered Investment Advisors and retail investors cumulatively account for significant proportion of US equity market assets under management
• SRAX’s Sequire platform bridges gap between corporations and their end investors
• SRAX recently introduced automated email and SMS functions, allowing companies to efficiently communicate with millions of retail investors on their platform
• Listed companies will also be able to search and interact with investment advisor community through Sequire’s proprietary search functions

Investment advisors make up a huge segment of the U.S. investor base; according to a recent survey carried out by RIA Channel, there were 14,955 independent registered investment advisors in the United States with cumulative assets under management of $2.969 trillion (https://ibn.fm/gkVER). Meanwhile, retail investors have increasingly become a dominant force within the U.S. equity market; a study carried out by Morgan Stanley revealed that retail investors accounted for close to 10 percent of daily trading volume on the Russell 3000, the broadest U.S. stocks index, after peaking at 15% in September 2020 as widespread lockdowns and increased savings triggered interest in the markets (https://ibn.fm/ecxI4). SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has sought to bridge the gap between listed corporations and the two investor sub-sets through the introduction of a number of novel features on its platform. As of May 2021, SRAX revealed that its Sequire platform had seen its corporate subscriber base swell to 183 publicly listed companies in addition to boasting a network of over five million influential, forward-thinking investors and shareholders. Sequire has recently released new features to help facilitate communication between its listed corporate subscribers and retail investor base, consisting of an automated email feature as well as an SMS function. Sequire’s listed corporate base will have access to custom filters to assist them in structuring campaigns directed at specific investor categories (https://ibn.fm/mmDe2), along with automation triggers, machine learning and other enhancements designed to promote frictionless communication between corporations and the millions of retail investors on their platform. “These new tools will allow companies to better manage communication with their shareholder base by defining pre-established triggers that will execute both email and SMS messages,” said SRAX Founder and CEO Christopher Miglino (https://ibn.fm/u0ITG). SRAX has simultaneously released new search features, enabling companies to access contact information on registered investment advisors. Banking on the knowledge that close corporate interactions with investment advisors make it more likely that a given investment advisor will recommend a company’s stock to clients, the investment advisor feature on Sequire will seek to assist issuers in developing significant connections and ties with the investment advisor community (https://ibn.fm/0deuy). SRAX’s corporate subscribers will be able to search and filter for specific types of advisors, designed to assist them in efficiently contacting their target audience. Moreover, in addition to assisting issuers in communicating with the advisors, the platform will also enable companies to track their subsequent participation in their listed equity. “Registered Investment Advisors have been the largest investors in our company SRAX and have been a significant part of the growth of our shareholder base. We are now providing the tools that will enable issuers to identify, communicate with and track the progress of specific advisors,” stated Christopher Miglino. For more information, visit the company’s websites at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• WTER’s distribution agreement calls for Giant Food to carry select WTER Alkaline88(R) and A88 Infused(R) offerings
• The distributor will offer WTER beverages in all 164 locations.
• Giant Food serves market of 60 million people with over $5 billion in sales.

In an move illustrative of  its continued commitment to expansion and growth, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) announced that it has partnered with Giant Food, the largest food retailer in the Mid-Atlantic region. The distribution agreement calls for Giant Food to carry select WTER Alkaline88 and A88 Infused offerings in all locations. “This is our biggest win to date in the Mid-Atlantic region,” said WTER president and CEO Ricky Wright. “Giant Food is the largest retailer in that market of 60 million people with over $5 billion in sales. While many retailers will test one or two product offerings, we are pleased to announce that Giant Food is carrying six products from our Alkaline88 and A88 Infused lines in their 164 locations. “The products include our one-gallon and 1.5-liter bottles, and naturally flavored Watermelon, Raspberry, Blood Orange, and Lemon single serves,” he continued. “This year, we expect these and our other single serves to significantly increase their overall contribution to our top line. We couldn’t have hoped for a better start to our fiscal 2022 expansion into the Mid-Atlantic and Northeast regions than being on the shelves in Giant Food. This is just the beginning of a larger push into the remaining untapped markets in the U.S.” Giant Food, a subsidiary of Ahold Delhaize, serves 164 stores in Maryland, Virginia, Delaware and Washington, DC. The company has been in operation for more than 80 years and has become an integral part of its customers’ lives and the communities it serves. The company’s commitment to providing its customers with the best is a perfect match with WTER’s dedication to offering the finest alkaline water products on the market. WTER’s Alkaline88 is known for its superior hydration with a perfect 8.8pH balance. The brand was developed to deliver what the company calls a Deliciously Smooth(TM) taste that encourages consumers to drink more and fully hydrate. The water’s ingredient deck is simple, easy to understand and free of buffers; it contains only two ingredients: purified water and Pink Himalayan Rock Salt. With the Giant Food announcement, the Alkaline88(R) flagship brand of premium alkaline water is now available in 75,000 stores across all trades in the United States. For more information, visit the company’s website at www.TheAlkalineWaterCo.com and www.a88CBD.com. NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

• Flora Growth is uniquely positioned to achieve revenue growth, with a balance sheet supported by two successful financings and the recent launch of multiple operating divisions
• The company boasts a robust M&A pipeline featuring strategic targets with near-term revenue growth opportunities and global distribution channels
• Flora Growth is led by an exceptional management team featuring cannabis, CPG, and capital markets experts who have raised more than $3 billion in combined public financings
• The company’s brand portfolio features 280+ products, 70+ medical and cosmetic licenses, and 2,500+ points of distribution across Latin America and the U.S.
• Flora Growth has a healthy balance sheet with minimal debt; the company reported a cash balance of $25.3 million with long-term debt of just $0.7 million as of April 19, 2021
• The company’s all-natural, outdoor cultivation operations allow for production costs below $0.06 per gram – roughly 60% lower than its closest peer

Flora Growth (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive. Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors. Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth. Existing Brand & Product Portfolio Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability. Flora Lab S.A.S Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas. Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products. Flora Beauty Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business. Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets. KASA Wholefoods KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country. Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan. Hemp Textiles & Co. Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment. The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021. Accretive M&A Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins. To date, Flora has announced two major transactions. Koch & Gsell (Acquisition)

• Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million
• Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets
• Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis

Hoshi International (Investment)

• Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities
• Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
• Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth

Cultivation Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram. Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward. Leadership Team Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices. Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard. Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia. Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England. Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• The study indicated enhanced delivery of colchicine using the company’s proprietary DehydraTECH(TM) technology
• Lexaria collaborates with the National Research Council (“NRC”), Canada’s leading research and technology organization
• The company has 20 patents granted and over 50 pending patents in over 40 countries around the world
• The global market for advanced drug delivery systems was valued at $231 billion in 2020 and is expected to grow to $310 billion by 2025

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the tolerability and pharmacokinetic study entitled VIRAL-A20-3 was completed and yielded positive results. The study demonstrated that administration of colchicine using the company’s proprietary DehydraTECH(TM), formulation and processing, resulted in increased delivery, according to a company press release (https://ibn.fm/AXBcz). Colchicine is an approved therapeutic with anti-inflammatory effects primarily used to treat gout and cardiac conditions such as pericarditis. It was the latest of several drugs Lexaria tested with known SARS-CoV-2/COVID-19 antiviral properties after it showed potent effects in mitigating the cytokine storm associated with the virus. Additionally, colchicine is occasionally used to treat emergent pericarditis in children, which would make the substance potentially beneficial against this form of cardiac inflammation when it occurs as a side effect of mRNA COVID-19 vaccines. The study was performed using Sprague-Dawley rats, with 20 dosed through oral gavage using DehydraTECH or control colchicine formulations. Performed by an independent, premier animal testing laboratory in the United States, the study evaluated both peak concentration and total drug delivery into the rodent’s bloodstream. As colchicine has a narrow therapeutic index, which means there is a marginal difference between toxic and non-toxic doses, Lexaria hopes that by using DehydraTECH it can improve its bioavailability beyond current levels of approximately 45 percent, which would potentially allow lower dosing requirements. Lexaria’s DehydraTECH promotes fast-acting, less expensive, and more effective oral drug delivery. The method has been evaluated thoroughly through in vivo, in vitro, and human clinical testing. The company has shown, through animal studies, that DehydraTECH technology elevates the quantity of drugs delivered across the blood-brain barrier by as much as 1,900%. This research has initiated new patent applications and opened the possibilities for improved drug delivery. The company has licensed its proprietary technology to multiple companies for use in different industries, including tobacco and nicotine products, cannabinoid beverages and edibles and more. Lexaria’s intellectual property portfolio consists of 20 patents granted and more than 50 patents pending in over 40 countries worldwide. Lexaria is currently collaborating with the National Research Council (“NRC”), the Canadian government’s leading research and technology organization. The Company has already filed for patent protection for specific nicotine delivery, NSAIDs, vitamins, estrogen, testosterone, terpenes, cannabinoids, PDE5 inhibitors (like Viagra), tobacco, and more. DehydraTECH is designed for formulating and delivering fat-soluble drugs and active ingredients, increasing their effectiveness and improving the way active pharmaceutical ingredients enter the bloodstream. The benefits of a DehydraTECH-enabled drug or consumer product are:

• Delivery is sped up, making the effects felt by the consumer in a matter of minutes
• The bioavailability is increased, making the delivery to the bloodstream much more effective and possibly requiring lower doses
• Animal testing has evidenced that there is a significant increase in the amount of the formulation crossing the blood barrier
• For consumer products, eliminates or reduces the need for sweeteners that are often used to mask the unwanted taste of the substance

This technology has the potential to revolutionize the global market for advanced drug delivery systems by changing the way treatments are administered and increasing overall bioabsorption and bioavailability. The drug delivery market is expected to reach a revenue of $310 billion by 2025 from $231 billion in 2020, marking a CAGR of 6.1% (https://ibn.fm/gGqYu). Right now, one of three areas of focus for Lexaria is on the antiviral drug market, which is anticipated to reach $52.1 billion in 2021 and grow to $66.7 billion by 2025. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Israeli Patent Office grants patent for new-generation, natural, disinfecting composition and method to protect edible matter from decay
• Patent is further validation of SVFD’s technology, an important step in building company’s IP portfolio
• Food waste is a social, humanitarian, economic and environment concern

Save Foods (NASDAQ: SVFD), an agri-food tech company focused on creating solutions to food waste and loss as well as food safety, has been granted its seventh global patent, protecting the company’s innovative ecofriendly product-treatment offerings (https://ibn.fm/XGHjr). The patent was granted by the Israeli Patent Office for SVFD’s new-generation natural disinfecting composition and method to protect edible matter from decay, ultimately extending extend shelf life and reduce waste. “Israel is a world-leader in agricultural technologies and a major exporter of fresh produce,” said Dr. Neta Matis, vice president of R&D for Save Foods Ltd.’s Israel subsidiary. “Israel is a key jurisdiction for us to protect our proprietary technologies, and this patent is further validation of our technology and an important step in building an IP portfolio that ensures food safety reduce waste globally.” The patent is Save Foods’ fourth issued patent in Israel and its seventh global patent. These patents are representative of the success of Save Foods’ dedication to addressing two major global issues: food waste and loss, and food safety. At face value, the implications of food waste are immense, with one recent report noting that “the amount of food waste in America alone is simply mind numbing, weighing in at 133 billion pounds and $161 billion worth of food in 2010. That means 31% of all food produced annually is wasted. As a subcategory, 644 million tons of fruit and vegetables, or 42% of total supply, is wasted annually” (https://ibn.fm/MOtc3). In fact, however, “food waste is a social, humanitarian, economic and environment concern. Understand that waste isn’t just what gets thrown away in a kitchen, grocery store or hotel. It also includes product that never leaves the farm or spoils during distribution. Collect those billions of pounds of waste, and there are enough calories to feed every undernourished person on the planet,” the report noted. “Now think about all the energy that was used, not to mention the trillions of gallons of water, to grow, harvest, package and transport the 133 billion pounds of fruit, vegetables, meat and more that ultimately ended up in the Dumpster. “If the United States, along with the rest of the world, genuinely wants to meet carbon reduction targets by 2030, all involved need to take a close look at food waste, considering it accounts for about 8% of global emissions. According to Project Drawdown, when accounting for deforestation for farmland and annual adoption of plant-rich diets, reducing food waste by 50% to 75% by 2050 would reduce carbon dioxide emissions by up to 95.1 gigatons.” Save Foods offers the first natural product with potential to actually replace the different highly residual (hazardous) chemicals used today while also addressing the challenges of both food waste and food safety. The company’s core applications are ecofriendly, post-harvest treatments for fruits and vegetables. SVFD’s proprietary technologies reduce the need for conventional post-harvest fungicide by at least 50% — even entirely in some cases — can reduce food loss due to spoilage by up to 50%. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and the consumers alike. For more information, visit the company’s website at www.SaveFoods.co. NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD

• Canadian-based clean energy solutions innovator FuelPositive Corp. began trading on the OTCQB Venture Marketplace July 21 to increase its North American presence among investors
• The company will also continue trading on the TSX Venture Exchange in Canada
• FuelPositive’s primary IP strategy is to develop scalable and easily transportable commercial ammonia production units that are non-polluting and able to help the carbon-intense ammonia industry evolve
• The company is also increasing its ability to work with the Canadian government on mutual goals by hiring Sussex Strategy Group to provide government relations services
• The potential applications of FuelPositive’s technology extend beyond the agriculture industry, which provides about 80 percent of the world’s demand for ammonia currently, to potential non-polluting fuel for combustion engines and a solution for grid-storage

Canadian-based growth-stage company FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has kicked in the boosters on its flight toward commercialization of its clean energy IP with the announcement July 21 that its common shares have begun trading on the OTCQB Venture Marketplace under the symbol NHHHF. “We’ve been in application now for a number of months and have gone through all of the qualifications to graduate to the QB so we’re very excited, really for our U.S.-based investors. We have a lot of retail investors in the U.S. and we expect that this will create a lot easier access to trading our stock,” CEO Ian Clifford said (https://ibn.fm/NzXlf). FuelPositive is dedicated to helping the fight against climate change through the development of green solutions that are accessible to the public and that improve on current technologies. The company is currently developing a patent-pending first-of-its-kind carbon-free ammonia (“NH3”) technology that provides a more efficient alternative to current ammonia production through modular, on-site capabilities. Ammonia production is a multi-billion-dollar industry that primarily supplies agricultural needs, an absolutely necessary food-production commerce chain but also a large source of the world’s greenhouse emissions. But FuelPositive’s solution would not only improve the environmental footprint of industry associated with agriculture, it also has the potential to expand into alternative applications including non-polluting fuel for combustion engines and a solution for grid-storage. “Beyond agriculture, there are numerous applications where our carbon-free NH3 can make a massive difference. For instance, we are exploring using our system to provide clean energy for northern and remote communities – that would be an ideal project for us to work on in partnership with governments,” Clifford stated (https://ibn.fm/tN8AK). FuelPositive’s debut on the OTCQB Venture Marketplace grants it greater visibility and liquidity as its potential for growing its investor audience is realized. “We believe the exciting promise of our carbon-free ammonia (‘NH3’) and its role in significantly reducing greenhouse gases across multiple sectors will resonate with institutional and retail investors within the U.S. investor community, opening up enhanced opportunities for engagement,” Clifford stated in a news release about the development (https://ibn.fm/rZw4d). The Company’s common shares will continue to be traded on the TSX Venture Exchange in Canada with its existing symbol NHHH as part of its efforts to build its North American presence. Clifford’s statement on alternative clean energy applications noted that the company has hired Sussex Strategy Group to provide government relations services in Canada, helping the company build on mutual goals it shares with the government under the Paris Agreement. FuelPositive’s carbon-free ammonia product takes air, water and sustainable electricity and converts it into a non-polluting chemical formulation of nitrogen and hydrogen (“NH3”) that can economically, efficiently and quickly produce, store, transport and use hydrogen, which supports current hydrogen fuel economy efforts. FuelPositive’s IP strategy is to develop scalable and easily transportable non-polluting commercial ammonia production units that will allow their end users to make clean NH3 onsite, “wherever it is needed, when it is needed.” The existing ammonia market has been a commodity-type market with a CAGR of 5 percent but the company states that several recent projections suggest the carbon-free ammonia market can achieve a 50 percent CAGR or more in the next decade. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Mobius.bet has teamed up with top Esports company Epulze to launch the Mobius.bet Maestros – Dota 2 Tournament
• This South American tournament features a $10,000 Prize pool
• The Mobius.bet Maestros – Dota 2 Tournament runs from July 26th to August 5th

Mobius Interactive Ltd., an online Esports gaming operator, announces the Dota 2 Mobius.bet Maestros tournament in South America. This tournament features a $10,000 prize pool. To deliver this ground breaking Esports event, Mobius Interactive’s flagship site, Mobius.bet has teamed up with top Esports provider Epulze. Epulze provides a world class online platform that launches promising amateur players into the exciting and rapidly expanding world of professional Esports. Epulze also produces a wide variety of professional tournaments while hosting their own livestream productions. Having served hundreds of thousands of players in over 60,000 online tournaments—Epulze provides all levels of gamers with a safe and exciting venue for their sport. The main event will take place from July 26 through August 5th.The Mobius.bet Maestros has 8 participating teams, 7 being direct invites, while the remaining slot will be picked up by the top team from the open qualifier. The main event will consist of a Bo2 Round Robin group stage with 1 group. The top 4 teams will then advance to a double elimination playoff. Ultra Play, Mobius Interactive’s award-winning Esports platform provider, is hosting the online “Beat the Pro” event throughout the tournament. Participating Teams: SG Esports, Team UNH (Team Unknown), Infinity, Noping Esports, Binomistas, INF.UEsports, Hokori, and the qualifier winner. Lynn Pearce, Co-Founder and CEO of Mobius Interactive, sees great potential in this emerging market: “The moment Team Mobius has been waiting for has finally arrived! We have gone live with our first Esports online tournament into Brazil, Peru and the rest of the Latin American market. We are so proud to be doing this with the amazing Epulze team, their professionalism is truly astounding and we are very grateful that they chose to run this exciting Esports online tournament in Brazil with Mobius.bet. We look forward to a long-term partnership with Epulze and to the success of our first tournament in the region, running until 5th August 2021.” The event is being broadcast in English, Spanish and Portuguese on Epulze’s own and partnered channels: English: Epulze, Spanish: 4D Esports, and Portuguese: Aldeia TV. Pontus Lövgren, Epulze Co-Founder and Director of the event, is “very excited to be working with Mobius.bet.” “This partnership will give us a good opportunity. Mobius.bet Maestros will be the first in a long series of tournaments in the region and we’re happy to have Mobius.bet onboard.” Mobius Interactive Ltd. provides a variety of unique offerings catering to diverse demographic groups, powered by the award winning UltraPlay Esports platform. Their flagship brand, Mobius.bet, combines loyalty and targeted gamification into one seamless package. As a top sponsor of the 2021 FIFA World Cup Qualifiers in Brazil, the Mobius.bet brand will be seen by up to 40 million people per game on Globo TV. The team at Mobius Interactive Ltd. collectively bring over 40 years of hands-on experience to the industry. Team Mobius has created a unique iGaming experience: one that caters to the client through gamification, loyalty rewards, and exceptional customer service throughout the player journey. Mobius Interactive is open for investment opportunities. For further information please contact: Gary Eldridge – President 1 (604) 783-1685  gary@mobiusinteractive.ltdSeamus Byrne – VP Corporate Development 1 (902) 441-5757  seamus.byrne@halifaxcitrus.caTracey Miller – VP Mergers & Acquisitions 1 (604) 355-5589  tracey@mobiusinteractive.ltd For more information, visit the company’s website at www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• Accure Acne’s groundbreaking Accure Laser System is the first commercially developed energy-based device that selectively targets and neutralizes overactive sebaceous glands
• The innovative technology is expected to position Accure as a disruptor on the vast global market of acne treatments
• By targeting only overactive glands, the system offers enhanced efficacy and a durable response; safety and efficacy have been confirmed by four IBR-approved clinical trials
• An early adopter program is already underway in the European Union, with the first orders received and delivered in Italy in Q2 2021; a broader commercial launch in several European countries is currently slated for H2 2021
• The company restarted a pivotal acne study in January 2021, with initial results expected in early 2022; this study will be essential for FDA approval in view of beginning U.S. commercialization in 2022
• Accure Acne boasts highly experienced management and scientific teams, leveraging decades of expertise in the aesthetics and medical device markets
• The company was co-founded by one of the most influential scientists in the field of energy-based devices and the co-developer of microscopic target-selective laser therapy

Accure Acne is a privately-owned medical device company focused on developing an innovative and highly efficient solution to reducing and/or preventing the recurrence of acne vulgaris. The company’s patented and patent-pending laser technology was designed to help improve acne sufferers’ long-term quality of life by offering a differentiated and impactful solution. Leveraging the extensive experience of its management and scientific teams, paired with a clear go-to-market strategy and commercialization and regulatory expertise, Accure remains committed to developing a uniquely compelling value proposition. Accure Acne is headquartered in Boulder, Colorado. The company’s flagship product, the Accure Laser System, was granted CE Mark approval for the treatment of moderate inflammatory acne in 2020, which allows the company to commercialize its product in the European Union while working to develop an exclusive global IP portfolio. Accure Laser System The company’s pioneering technology has the potential to disrupt the vast global market of acne therapeutics. It is estimated that there are 40-50 million people affected by acne vulgaris in the United States each year, while roughly 85 percent of the global population will suffer from acne at some point, according to the company’s April 2021 investor presentation. In 2016, the acne vulgaris market was estimated at $2.6 billion in the U.S. alone. Accure Acne is leveraging several competitive advantages to position itself as a leading company in the acne treatment market. Compared to the main competitors and other acne treatments in the market, the Accure Laser System is designed for efficacy and durable results, in a cost-effective treatment package. This groundbreaking system is the first commercially developed energy-based device that selectively targets and neutralizes overactive sebaceous glands present in the skin, which are the main source of sebum production and acne vulgaris. By targeting only overactive glands without damaging the surrounding epidermis, the Acne Laser System is likely to yield a durable response, starting with a significant reduction of inflammatory acne lesions, with the goal of eliminating inflammation recurrence in treated areas. The system has been shown to yield a 45%+ reduction in inflammation after just one treatment. Other key features of the Accure Laser System include:

• Utilizes a unique wavelength that has not previously been clinically available
• Leverages unique pulsing strategy, precise and safe closed-loop laser control and integrated temperature monitoring through an infrared camera
• Is designed for ease of use and relatively short treatment time (30 to 45 minutes)
• Is equipped with single-use treatment tip and accessories

Treatments are customized to each patient, depending on skin types and case severity, and can range from one to six treatment sessions administered three to six weeks apart. Accure Acne believes its technology is the only 1,726 nm laser with CE Mark Clearance for acne treatment on the market. The Accure Laser System was developed in partnership with Quanta System, a Milan, Italy, laser tech developer with over four decades of experience. The company has already launched an early adopter program in the European Union, with the first orders received and delivered in Italy in Q2 2021, through Quanta’s distribution channel. A broader EU commercial launch is scheduled for H2 2021, with plans for an early adopter program in the U.S. to begin in H1 2022 and broader commercial launch in H2 2022. New Pivotal Acne Study The Accure Laser System’s efficiency and safety of treatment across all genders, ages, races and skin types has so far been confirmed through four IRB-approved clinical studies. Research showed a 45% reduction of acne lesions after just one treatment and an 80% reduction after the fourth treatment. Accure Acne is now conducting a new pivotal acne study, restarted in January 2021, based on safety reports from the four IRB-approved clinical trials. This open-label study will enroll 75 patients 16 years and older who will undergo four treatments approximately one month apart. The study is expected to be completed in early 2022, following several checkpoints to monitor for progress and durability – at three months, six months, nine months and 12 months after the fourth and final treatment. This clinical trial will be key to the company’s efforts to secure FDA approval in the United States. Private Placement Offering Accure Acne launched a private placement offering pursuant to Rule 506(c) of Regulation D under the Securities Act. The private placement, launched in April 2021 on the M-Vest platform, aims to raise up to $20 million in Series A Convertible preferred stock. The proceeds will be used to fund the pivotal acne study, ongoing operations and infrastructure needs, while also creating an EU-based sales team and global marketing teams and conducting pre-commercialization operations in the U.S. For more information, visit the company’s offering page on M-Vest. Management Team Christopher Carlton is Co-Founder, Chief Executive Officer and Chairman of the Board of Accure Acne. He has extensive industry experience as well as a demonstrated track record of entrepreneurial success with high-growth public companies and new product launches on the global medical and aesthetic markets. His previous tenures include CEO of Quanta Aesthetic Lasers USA LLC; President, NA for Syneron-Candela, a prominent company in the aesthetic energy-based device market; Vice President and Global General Manager – Interventional Oncology for Covidien Ltd.; CEO for SRI Surgical; and other leadership positions. In 2016, he was recognized as one of the top 10 CEOs and presidents in the industry by Aesthetics Everything(R). Mr. Carlton is a graduate of the GE Management Development Institute-Crotonville and the Program on Negotiation at Harvard Law School, and he holds a BS in Industrial Engineering (With Honors), a Graduate Diploma in Management and an MBA. R. Rox Anderson, MD, is the company’s Co-Founder and Chief Scientific & Medical Officer. One of the most influential scientists in the field of energy-based devices in aesthetics and widely considered the father of the aesthetic industry, Dr. Anderson has contributed significant advancements to acne treatment efforts, including pre-clinical, clinical and product development activities built upon his conceptualization and co-development of microscopic target-selective laser therapy. He has been awarded over 60 national and international patents and has co-authored over 437 scientific books and papers cited by other researchers more than 22,800 times. Dr. Anderson is a Harvard Medical School Professor in dermatology, Director of the Wellman Center for Photomedicine, and adjunct Professor of Health Sciences and Technology at Massachusetts Institute of Technology. Edward Barbera is Co-Founder and Director of Accure Acne. He has more than 35 years of experience developing, running and investing in startups, as well as fundraising, having secured more than $50 million in private equity for a company he founded. Mr. Barbera began his career as a Senior Consultant with Peat, Marwick, Mitchell & Co. and has since held key leadership roles in business development, acquisitions, capital formation and the operation of numerous startups. He has a Bachelor of Business Administration degree with a major in accounting from the University of Massachusetts – Amherst and has previously been a member of the National and Colorado Societies of CPAs. The Accure Acne leadership and medical teams are further comprised of experts and professionals with extensive experience in technology, software, engineering and medical devices, as well as specialists in acne treatment and laser-based treatment options in dermatology and other medical fields. For more information, visit the company’s website at www.AccureAcne.com. NOTE TO INVESTORS: The latest news and updates relating to Accure Acne are available in the company’s newsroom at https://ibn.fm/ACNE

• While all wines are plant-based, not all of them are vegan because traditional winemaking employs animal-based fining agents
• Vegan wines are clarified and stabilized using either bentonite or natural settlement, but vegans struggle to find such wines
• PlantX recently added vegan wines to its expanding product selection on its US e-commerce platform, targeting the growing population of vegans in the US
• The move also appears to be leveraging the trends in both the alcoholic beverage market and the e-commerce sector

While all wines are derived from grapes and sometimes yeast – meaning they are plant-based – not all wines are vegan. This is because some aspects of traditional winemaking, particularly the fining process, employ animal products. A process that stabilizes and clarifies the wine by removing hydrogen sulfide, bitter flavors (or rough tannins, to wine fiends), and microscopic particles that may cause the wine to become cloudy or hazy after bottling, fining typically uses egg whites, as well as fish and milk derivatives. This creates an end product that isn’t vegan – vegans do not consume any form of animal product. In contrast, vegan wines, which still undergo the fining process, do not use animal derivatives. Wineries instead rely on bentonite, a clay, or forego fining agents altogether – given ample time, the impurities settle naturally out of the wine. So, according to a 2018 Washington Post article, the use of animal-based fining agents may not be as widespread as many think (https://ibn.fm/PXiUx). However, because most of the wines available for sale are usually mass-produced and rushed to the market, one cannot be too sure. In fact, vegans have voiced their frustrations at not readily finding vegan wines in shops or restaurants (https://ibn.fm/EONQb). This is where PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a company intent on redefining the plant-based community through e-commerce, comes in. PLTXF recently announced it is now offering vegan wines as part of its expanding product selection on its US e-commerce platform. The addition, announced July 12, will feature a curated selection of high-quality vegan wines from Gravel Bar Winery, Pino Cellars, Veuve Clicquot, and Rare Earth (https://ibn.fm/qWi5u). “The alcoholic beverage market is one of the fastest-growing industry segments in the US and globally,” stated PlantX CEO Julia Frank. “The new vertical will allow PlantX to holistically meet customer demands and expectations by expanding its product offerings in line with its mission and values.” Findings contained in IWSR’s recent Drinks Market Analysis corroborate Julia’s observations. In 2020, the total alcoholic beverage consumption volume increased by +2.0%, the most significant growth since the early aughts. IWSR’s projections show that the consumption volume for 2021 will be up +3.8%. Such positive statistics are also replicated in e-commerce, especially given that the pandemic spawned increased online alcohol sales. “E-commerce alcohol sales in the US are expected to see average annual growth of nearly 45% in value over the next four years,” said IWSR’s COO Brandy Rand (https://ibn.fm/dzcLd). PlantX’s inclusion of vegan wines as part of its online portfolio, therefore, appears to be leveraging the trends in both the alcoholic beverage market and e-commerce sector. Additionally, this latest move embodies the company’s commitment to becoming the one-stop shop for everything plat-based by addressing the needs and wants of its customers, including the growing vegan community in the US, in the most comprehensive and holistic ways. “We consider the PlantX community our own family and obsess over meeting their needs while exceeding customer expectations,” reads the company’s website. The addition of vegan wines on its US platform fulfills this commitment. Just recently, PlantX moved to leverage the pandemic-induced shopping habits in Canada by partnering with two established online marketplaces, in effect meeting the needs of the majority of consumers who have since shifted to e-shopping. PlantX is a high-growth company focusing on consumer-packaged goods (“CPG”) for the plant-based community. Its e-commerce platform offers customers across North America access to more than 10,000 plant-based products. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF